Clinical Trials Browser

Phase 1/2 × Disease × Gastrointestinal × Clear all

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Bronchogenic, Disease, Esophageal Neoplasms, Glioblastoma, Kidney Neoplasms, Leukemia, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms

NCT07244705 2025-11-24

A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC

Phase 1/2 Recruiting

66 enrolled

Gastrointestinal

Disease, Colorectal Neoplasms

NCT01730222 2017-09-01

PACT-19

Phase 1/2 Completed

137 enrolled

Gastrointestinal

Disease, Pancreatic Neoplasms

Clinical Trials

EBNK-ST-001

A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC

PACT-19